Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty

Delayed resolution of obstructing thrombus following acute closure

A case of acute thrombotic closure following percutaneous coronary angioplasty demonstrating delayed clearance of obstructing thrombus is reported. Although common in other clinical scenarios this has not been reported following coronary angioplasty.

Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging

BACKGROUND

Histological examination of the effects of balloon angioplasty have been described from in vitro experiments and a limited number of pathologic specimens. Intravascular ultrasound imaging permits real time cross-sectional observation of the effect of balloon dilation on the atherosclerotic plaque in vivo.

METHODS AND RESULTS

The morphological effects of coronary angioplasty were visualized at 66 lesions in 47 patients immediately after balloon dilatation with an intravascular ultrasound imaging catheter. Cross-sectional images were obtained at 30 frames per second as the catheter passed along the length of the artery. Quantitative and qualitative assessments of the dilated atherosclerotic plaque were made from the angiograms and the ultrasound images. Six morphological patterns after angioplasty were appreciated by ultrasound imaging. Type A consists of a linear, partial tear of the plaque from the lumen toward the media (seven lesions); Type B is defined by a split in the plaque that extends to the media (12 lesions); Type C demonstrates a dissection behind the plaque that subtends an arc of up to 180 degrees around the circumference (18 lesions); Type D was a more extensive dissection that encompasses an arc of more than 180 degrees (four lesions); and Type E may be present in either concentric (Type E1, 14 lesions) or eccentric (Type E2, 11 lesions) plaque and is defined as an ultrasound study without any evidence of a fracture or a dissection in the plaque. There was a large amount of residual atheroma in each type of morphology (7.8 +/- 2.9 mm2, 61.6 +/- 15.4% of cross-sectional area); there was no difference, however, in lumen or atheroma cross-sectional area among these six patterns. There was a good correlation between ultrasound and angiography for the recognition of a dissection. Calcification was seen in only 14% of lesions on angiography, whereas most lesions (83%) revealed calcification on ultrasound imaging. As determined by intravascular ultrasound, calcified plaque was more likely to fracture in response to balloon dilatation than noncalcified plaque (p less than 0.01). Thirteen of 66 lesions (20%) developed clinical and angiographic restenosis. Restenosis was more likely to occur when the original dilatation left a concentric plaque without a fracture or dissection (Type E1, 50% incidence) compared with a mean restenosis rate of 12% in the remaining morphological patterns (p = 0.053).

CONCLUSIONS

Intravascular ultrasound provides a more complete quantitative and qualitative description of plaque geometry and composition than angiography after balloon angioplasty. In addition, intravascular ultrasound identified a subset of atherosclerotic plaque that has a higher incidence of restenosis. This information could be used prospectively to consider other therapeutic options in this subset. Intravascular ultrasound provides a method to describe the effects of angioplasty that will be useful in comparing future coronary intervention studies.

Quantitative and qualitative coronary angiographic analysis: review of methods, utility, and limitations

Coronary angiography continues to be the pivotal study in the diagnosis and treatment of ischemic cardiac disease. Although angiographic equipment and imaging techniques have advanced over the past three decades, the analysis of coronary angiograms, by visual estimated percent diameter stenosis, has remained unchanged in most clinical catheterization laboratories. Rapid, computerized angiographic analysis systems are now available that remedy the inherent imprecision and inaccuracies plaguing visual coronary analysis. Despite its advantages, successful QCA is quite dependent on meticulous attention to radiographic and angiographic technique, even more so than with visual analysis. Although the available QCA systems can reproducibly and accurately define the site and degree of coronary stenosis, they cannot routinely determine whether an obstruction is flow limiting. Several methods, some based on extrapolations of quantitative measures alone, and others based on digital subtraction angiography, have been developed to determine the physiologic impact of a given coronary lesion. Recent observations have demonstrated, however, that even if the physiologic consequences of an obstruction are known, the prognosis of the lesion over time cannot be predicted. The qualitative, morphologic characteristics of a lesion are as, or more, important than the quantitative lesion attributes in determining an atheroma's behavior and stability, and hence, qualitative descriptors should be incorporated into QCA analyses. Although not currently available, future QCA systems will provide, by automated analysis, reproducible and accurate measures of absolute obstruction, physiologic data describing the flow limiting characteristics of a lesion, and qualitative, morphologic lesion descriptors. Implementation of these systems should provide more consistent and accurate prognostic and pathophysiologic information, thereby helping to refine and more effectively direct therapeutic interventions in coronary artery disease.

Real-time assessment of experimental arterial angioplasty with transvenous intravascular ultrasound

Optimal evaluation of experimental angioplasty procedures would allow real-time simultaneous assessment during the procedure without direct manipulation of treated arterial segments. To assess the feasibility and utility of transvenous real-time intravascular ultrasound imaging during experimental angioplasty, 11 consecutive atherosclerotic iliac artery segments in rabbits were imaged before, during and after thermal or conventional perfusion balloon angioplasty. A 20-MHz intravascular ultrasound catheter was positioned in the adjacent vein, and images were correlated with data from quantitative angiography and histologic studies. Images suitable for analysis were obtained at all 11 sites. Arterial distension and recoil were observed during balloon inflation and deflation. Measurements of lumen diameter and cross-sectional area by intravascular ultrasound and angiography were closely correlated (r2 = 0.90, SEE = 0.2 mm, and r2 = 0.90, SEE = 0.8 mm2, respectively). Intimal dissections were identified in six segments by intravascular ultrasound and all were concordant with histologic findings. Thus, real-time transvenous ultrasound avoids manipulation of the treated artery, and is a feasible modality for dynamic quantitative and qualitative assessment of arterial interventions.

Intracoronary ultrasound evaluation of interventional technologies

The feasibility and applicability of intravascular ultrasound (IVUS) of the coronary arteries were evaluated in 65 patients undergoing 70 coronary interventional procedures. Morphologic and quantitative analyses were performed with a mechanically rotated IVUS catheter (4.8Fr, 20 MHz) and with orthogonal view cineangiography. A semiautomated edge-detection algorithm was used for cineangiographic quantification. Coronary interventions included 45 percutaneous transluminal coronary angioplasties, 9 excimer lasers, 11 directional coronary atherectomies, 3 rotational atherectomies and 2 stents. Most lesions consisted of a mixture of plaque composition (hard, n = 30; soft, n = 64). Other unique morphologic data by IVUS were plaque topography (eccentric, n = 34; concentric, n = 36) and vessel dissection (IVUS [n = 29] versus angiography [n = 14], p less than 0.05). Postprocedure minimal lumen diameter and cross-sectional area measured by IVUS were larger and poorly correlated with angiography (r = 0.28, standard error of the estimate = 0.52 mm; r = 0.08, standard error of the estimate = 1.0 cm2, respectively). IVUS is more sensitive than angiography when assessing postintervention lesion characteristics including vessel dissection and plaque morphology. Catheter-based ultrasound appears to be a useful adjunct to contrast angiography when evaluating and comparing the therapeutic impact of conventional percutaneous transluminal coronary angioplasty with new technologies.

Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty

Local delivery into the arterial wall of medications at high concentrations may evolve as a method to reduce postangioplasty restenosis. However, since the atherosclerotic artery has increased vasa vasorum, medications injected in a fluid state may diffuse out of the arterial wall too quickly to have a therapeutic effect. Thus we evaluated whether microparticles as a model for a particulate microcarrier drug delivery system, injected via a porous balloon catheter, could be retained within the atherosclerotic rabbit femoral arterial wall. Arteries were injected with a 5 microns microparticle suspension for 45 seconds at either 3 or 5 atm of infusion pressure immediately following balloon angioplasty. Arteries were obtained immediately following the procedure or at 1, 3, 7, or 14 days after infusion to evaluate for the presence of retained microparticles. Of 34 arteries, 30 contained retained microparticles, with 21 exhibiting microparticles in the neointimia, 12 in the media, and 25 in the adventitia. Microparticles were retained for as long as 14 days, and there was no difference between the distribution or quantity of microparticles at 3 or 5 atm of infusion pressure. The mode of microparticle distribution probably involved deposition within dissection planes, although evidence for vasa vasorum transport was observed. We hypothesize that biodegradable microparticles could serve as a vehicle for intramural drug delivery in the treatment of restenosis.

The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty

Coronary angioplasty has become a successful and widely used treatment for patients with coronary artery disease since its first clinical application in 1977. The primary success rate has improved despite the increase in procedure and case complexity. However, acute reocclusion and late restenosis, which constitute the most important problems after successful angioplasty, continue to occur in about 5% and 35% of patients within 3 to 6 months, respectively. Angioscopic and pathologic observations have suggested that a multifactorial pathophysiologic process accounts for acute reocclusion, involving marked thrombosis, intimal dissection, medial and subintimal hemorrhage, vascular recoil and vasocontriction. In contrast, chronic restenosis involves the development of fibrocellular intimal hyperplasia within a milieu created by vascular injury, platelet activation, thrombin generation and the release of mitogens. Although current pharmacologic approaches, which involve antithrombotic and anticoagulant therapy, have been largely ineffective in eliminating acute reocclusion and chronic restenosis, recent advances in the research in thrombosis, platelet receptors and smooth muscle growth regulation have allowed new therapeutic options to be tested in the experimental setting, with subsequent potential clinical applications in patients.